Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Different Doses of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome：An Open-label Randomized Controlled Trial

NCT07388810 is registered in ClinicalTrials.gov with Mao Jianhua as lead sponsor.

NCT NCT07388810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07388810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Different Doses of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome：An Open-label Randomized Controlled Trial
Lead sponsor
Mao Jianhua
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
February 29, 2028
Enrollment
312 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

frns/sdns, ripertamab